{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T10:57:26Z","timestamp":1738666646902,"version":"3.36.0"},"reference-count":32,"publisher":"Scientific Foundation Spiroski (publications)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Open Access Maced J Med Sci"],"abstract":"<jats:p>BACKGROUND: Hepatitis C virus is one of the most common etiologic agents of chronic liver diseases, including liver cirrhosis and hepatocellular carcinoma in which there is continuous inflammation and regeneration of hepatocytes.Cytokeratin-18 (CK18) has been suggested to play an important role in tumorigenesis of epithelial cancers.AIM: Estimation of CK18 serum levels in patients with chronic viral hepatitis C (CHCV) and hepatocellular carcinoma (HCC) and find the relationship between their levels, the severity of the disease and the development of HCC.METHODS: We measured serum levels of CK18 in 60 Egyptian patients (30 with CHCV &amp; 30 with HCC) and 30 healthy controls.RESULTS: Patients with HCC had highly significant increased CK18 levels compared with CHCV patients, healthy controls. Cytokeratin-18 among the three classes of Child-Pugh classification show highly significant gradual increase from child A to C. Furthermore, In HCC there were positive correlations between CK18 and with RBCs, ESR, and AFP.CONCLUSION: CK18 is a sensitive indicator of the severity of liver disease. Patients with CHCV infection can be followed up by measurement of its serum level which can predict the development of HCC. The combination of AFP and CK18 increased the sensitivity of detection for HCC.<\/jats:p>","DOI":"10.3889\/oamjms.2015.021","type":"journal-article","created":{"date-parts":[[2015,2,18]],"date-time":"2015-02-18T05:27:14Z","timestamp":1424237234000},"page":"117-123","source":"Crossref","is-referenced-by-count":6,"title":["Significance of Serum Cytokeratin-18 in Prediction of Hepatocellular Carcinoma in Chronic Hepatitis C Infected Egyptian Patients"],"prefix":"10.3889","volume":"3","author":[{"given":"Wafaa","family":"El-Zefzafy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanan","family":"Eltokhy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagwa Abd","family":"El-Ghaffar Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zakia","family":"Abu-Zahab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"52292","published-online":{"date-parts":[[2015,2,17]]},"reference":[{"key":"7981","doi-asserted-by":"crossref","unstructured":"Yousra A Mohamoud, Ghina R Mumtaz, Suzanne Riome, DeWolfe Miller and Laith J Abu-Raddad. The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis, BMC. Infectious Diseases. 2013; 13:288.","DOI":"10.1186\/1471-2334-13-288"},{"key":"7982","doi-asserted-by":"crossref","unstructured":"Strickland GT, Elhefni H, Salman T, Waked I, Abdel-Hamid M, Mikhail NN, et al. Role of hepatitis C infection in chronic liver disease in Egypt. Am J Trop Med Hyg. 2002; 67: 436\u00e2\u20ac\u201c442.","DOI":"10.4269\/ajtmh.2002.67.436"},{"key":"7983","doi-asserted-by":"crossref","unstructured":"Luedde T, Schwabe RF. NF-\u00ce\u00baB in the liver--linking injury, fibrosis and hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2011;8(2):108-18.","DOI":"10.1038\/nrgastro.2010.213"},{"key":"7984","doi-asserted-by":"crossref","unstructured":"El-Serag HB, Marrero JA, Rudolph L Reddy KR. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology. 2008;134:1752\u00e2\u20ac\u201c1763.","DOI":"10.1053\/j.gastro.2008.02.090"},{"key":"7985","doi-asserted-by":"crossref","unstructured":"Singal AG, Pillai A, Tiro J. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis. PLoS Med. 2014;11(4):e1001624.","DOI":"10.1371\/journal.pmed.1001624"},{"key":"7986","doi-asserted-by":"crossref","unstructured":"Padhya KT, Marrero JA, Singal AG. Recent advances in the treatment of hepatocellular carcinoma. Curr Opin Gastroenterol. 2013; 29: 285\u00e2\u20ac\u201c292.","DOI":"10.1097\/MOG.0b013e32835ff1cf"},{"key":"7987","doi-asserted-by":"crossref","unstructured":"Aghoram R, Cai P, Dickinson JA. Alpha-foetoprotein and\/or liver ultrasonography for screening of hepatocellular carcinoma in patients with chronic hepatitis B. Cochrane Database Syst. Rev. 2012; 9:CD002799.","DOI":"10.1002\/14651858.CD002799.pub2"},{"key":"7988","doi-asserted-by":"crossref","unstructured":"Zhao YJ, Ju Q, Li GC. Tumor markers for hepatocellular carcinoma. Mol Clin Oncol. 2013;1(4):593-598.","DOI":"10.3892\/mco.2013.119"},{"key":"7989","doi-asserted-by":"crossref","unstructured":"Schweizer J, Bowden PE, Coulombe PA, Langbein L, Lane EB, Magin TM, Maltais L, Omary MB, Parry DA, Rogers MA, Wright MW. New consensus nomenclature for mammalian keratins. J Cell Biol. 2006;174 (2): 169\u00e2\u20ac\u201c174.","DOI":"10.1083\/jcb.200603161"},{"key":"7990","doi-asserted-by":"crossref","unstructured":"Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, Tibbe AG, Uhr JW, Terstappen LW. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res. 2004;10(20):6897-904.","DOI":"10.1158\/1078-0432.CCR-04-0378"},{"key":"7991","doi-asserted-by":"crossref","unstructured":"Oshima RG. Apoptosis and keratin intermediate filaments. Cell Death Differ. 2002; 9: 486\u00e2\u20ac\u201c92","DOI":"10.1038\/sj.cdd.4400988"},{"key":"7992","doi-asserted-by":"crossref","unstructured":"Linder S. Cytokeratin markers come of age. Tumour Biol. 2007; 28: 189\u00e2\u20ac\u201c95.","DOI":"10.1159\/000107582"},{"key":"7993","doi-asserted-by":"crossref","unstructured":"Ausch C, Buxhofer-Ausch V, Olszewski U, Schiessel R, Ogris E, Hinterberger W, Hamilton G. Circulating cytokeratin 18 fragment m65-a potential marker of malignancy in colorectal cancer patients. J Gastrointest Surg. 2009;13(11):2020-6.","DOI":"10.1007\/s11605-009-0992-6"},{"key":"7994","doi-asserted-by":"crossref","unstructured":"Bantel H, L\u00c3\u00bcgering A, Heidemann J. Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury. Hepatology. 2004; 40: 1078\u00e2\u20ac\u201c87.","DOI":"10.1002\/hep.20411"},{"key":"7995","doi-asserted-by":"crossref","unstructured":"Qin X, Lin L, Mo Z, Lv H, Gao Y, Tan A, Yang X, Li S, Zhao J. Reference intervals for serum alpha-fetoprotein and carcinoembryonic antigen in Chinese Han ethnic males from the Fangchenggang Area Male Health and Examination Survey. Int J Biol Markers. 2011;26(1):65-7.","DOI":"10.5301\/JBM.2011.6364"},{"key":"7996","doi-asserted-by":"crossref","unstructured":"Sumer S, Demir AK, K\u00c3\u00b6lgelier S, Inkaya AC, Arpaci A, Demir LS, Ural O. The Clinical Significance of Serum Apoptotic Cytokeratin 18 Neoepitope M30 (CK-18 M30) and Matrix Metalloproteinase 2 (MMP-2) Levels in Chronic Hepatitis B Patients with Cirrhosis. Hepatitis Monthly. 2013; 13 (6): e10106.","DOI":"10.5812\/hepatmon.10106"},{"key":"7997","doi-asserted-by":"crossref","unstructured":"Shrivastava S, Mukherjee A, Ray RB. Hepatitis C virus infection, microRNA and liver disease progression. World J Hepatol. 2013;5(9):479-86.","DOI":"10.4254\/wjh.v5.i9.479"},{"key":"7998","doi-asserted-by":"crossref","unstructured":"Bantel H, L\u00c3\u00bcgering A, Heidemann J, Volkmann X, Poremba C, Strassburg CP, Manns MP, Schulze-Osthoff K. Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury. Hepatology. 2004;40(5):1078-87.","DOI":"10.1002\/hep.20411"},{"key":"7999","doi-asserted-by":"crossref","unstructured":"Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell. 2004; 116: 205\u00e2\u20ac\u201c219.","DOI":"10.1016\/S0092-8674(04)00046-7"},{"key":"8000","unstructured":"Madersbacher S, Gregor N, Theyer G, Steiner G, Marberger M. TPS is a useful epithelial proliferation and tumor marker. J Urol. 1992; 147:A911."},{"key":"8001","doi-asserted-by":"crossref","unstructured":"Mittal S, El-Serag HB. Epidemiology of hepatocellular carcinoma. Journal of Clinical Gastroenterology. 2013; 47 Suppl:S2-6.","DOI":"10.1097\/MCG.0b013e3182872f29"},{"key":"8002","unstructured":"Avunduk C. Tumors of the liver and biliary system. The Manual of Gastroenterology, Diagnosis and therap. 2008 ; 455-8. 4th edition Philadelphia,Lippincott William,Wilkins. PA1960USA. https:\/\/books.google.com.eg\/books."},{"key":"8003","doi-asserted-by":"crossref","unstructured":"Lu SN, Wang JH, Liu SL, Hung CH, Chen CH, Tung HD, Chen TM, Huang WS, Lee CM, Chen CC, Changchien CS. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma. Cancer. 2006; 107(9): 2212-22.","DOI":"10.1002\/cncr.22242"},{"key":"8004","unstructured":"Friedman LS, Martin P, Munoz SJ. Laboratory methods for evaluation of the liver disease. In Zakim D,Boyer TD,eds Hepatology: A Texextbook of Liver Disaes, 4th edn. Philadelphia: Saunders, 2002:661-708."},{"key":"8005","doi-asserted-by":"crossref","unstructured":"Gonzalez-Quintela A, Mallo N, Mella C, Campos J, Perez LF, Lopez-Rodriguez R, Tome S, Otero E. Serum levels of cytokeratin-18 (tissue polypeptide-specific antigen) in liver diseases. Liver Int. 2006;26(10):1217-24.","DOI":"10.1111\/j.1478-3231.2006.01380.x"},{"key":"8006","doi-asserted-by":"crossref","unstructured":"Collazos J, Genolla J, Ruibal A. A clinical and laboratory evaluation of the behavior of tissue polypeptide antigen in liver cirrhosis. Digestion. 1992; 53: 157\u00e2\u20ac\u201c61.","DOI":"10.1159\/000200991"},{"key":"8007","doi-asserted-by":"crossref","unstructured":"Tu DG, Wang ST, Chang TT, Chiu NT, Yao WJ. The value of serum tissue polypeptide specific antigen in the diagnosis of hepatocellular carcinoma. Cancer. 1999;85(5):1039-43.","DOI":"10.1002\/(SICI)1097-0142(19990301)85:5<1039::AID-CNCR5>3.0.CO;2-B"},{"key":"8008","doi-asserted-by":"crossref","unstructured":"Marquardt JU, Galle PR, Teufel A. Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): an emerging field for advanced technologies. J Hepatol. 2012; 56: 267-275.","DOI":"10.1016\/j.jhep.2011.07.007"},{"key":"8009","doi-asserted-by":"crossref","unstructured":"Patel M, Shariff MI, Ladep NG, Thillainayagam AV, Thomas HC, Khan SA, Taylor-Robinson SD. Hepatocellular carcinoma: diagnostics and screening. J Eval Clin Pract. 2012 ;18(2):335-42.","DOI":"10.1111\/j.1365-2753.2010.01599.x"},{"key":"8010","unstructured":"Gallo V, Cerutti E, Riberi A, Re M, Petrino R, Pecchio F. Alpha-fetoprotein and tissue polypeptide antigen in non neoplastic hepatic disorder. J Nucl Med Allied Sci. 1989; 33(3): 89\u00e2\u20ac\u201c93."},{"key":"8011","unstructured":"Kao CH, Gu CJ, Wang SJ. Tissue polypeptide specific antigen in hepatitis B carriers. Anticancer Res. 1994; 14:2817\u00e2\u20ac\u201c8."},{"key":"8012","doi-asserted-by":"crossref","unstructured":"Abdel Haleem H, Zayed N, Abdel Hafez H, Fouad A, Akl M, Hassan M, Hammam O, Morsy A, Saleh A, Seyam M, Zakaria Z, Zakaria S. Evaluation of the diagnostic value of serum and tissue apoptotic cytokeratin-18 in patients with chronic hepatitis C. Arab J Gastroenterol. 2013;14(2):68-72.","DOI":"10.1016\/j.ajg.2013.03.004"}],"container-title":["Open Access Macedonian Journal of Medical Sciences"],"original-title":[],"link":[{"URL":"https:\/\/oamjms.eu\/index.php\/mjms\/article\/download\/oamjms.2015.021\/373","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/oamjms.eu\/index.php\/mjms\/article\/download\/oamjms.2015.021\/342","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/oamjms.eu\/index.php\/mjms\/article\/download\/oamjms.2015.021\/373","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T13:41:39Z","timestamp":1624887699000},"score":1,"resource":{"primary":{"URL":"https:\/\/oamjms.eu\/index.php\/mjms\/article\/view\/oamjms.2015.021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,17]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,3,15]]}},"URL":"https:\/\/doi.org\/10.3889\/oamjms.2015.021","relation":{},"ISSN":["1857-9655"],"issn-type":[{"type":"electronic","value":"1857-9655"}],"subject":[],"published":{"date-parts":[[2015,2,17]]}}}